Latest Continuous Disclosure News

4DMedical Limited has responded to ASX queries over its announcements of commercial agreements with leading US academic medical centres, clarifying its disclosure approach and denying ramping allegations ahead of a $150 million capital raise.

Findi Limited has responded in detail to ASX queries over its valuation approach for its Indian subsidiary TSI, clarifying peer selection, valuation multiples, and compliance ahead of TSI’s planned IPO on the Bombay Stock Exchange.

ION Video Ltd has responded to an ASX price query following a notable jump in its share price, confirming no undisclosed information exists and highlighting an upcoming technology launch.

Klevo Rewards Limited has responded to ASX inquiries about a recent spike in its share price and trading volume, attributing the movement to a positive quarterly report and confirming full compliance with disclosure rules.

Paterson Resources has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information exists. The company points to imminent drilling results from its Grace Project as the likely catalyst for market activity.

ECS Botanics Holdings Ltd has seen its ECSO securities suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s next steps.

4DS Memory Limited reports steady progress in its strategic review focused on AI-related opportunities, alongside significant cost reductions and a solid cash position of $8.8 million at the end of December 2025.

Strategic Elements Ltd’s subsidiary Stealth Technologies has secured its inaugural commercial pilot deployment of the EdgeiQ system at an underground gold mine in Western Australia, marking a significant milestone in the technology’s commercialisation journey.

Critica Limited has addressed a recent spike in its share price and trading volume, attributing the movement to positive research coverage while confirming no undisclosed information is driving the activity.

Cyclopharm Limited confirms its insurer has assumed responsibility for defending the company in ongoing legal proceedings initiated by 4DMedical Limited. This development marks a significant step in managing the dispute’s financial and operational risks.

DTI Group Ltd has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information behind the market activity.

Novo Resources has responded to an ASX price query, attributing recent share price and volume spikes to insider buying and rising gold prices, while confirming no undisclosed material information.